BOSTON SCIENTIFIC CORP is 58.3x more valuable than IRADIMED CORP by market capitalization ($69.72 B vs $1.20 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | IRMD | BSX |
|---|---|---|
| Market cap | $1.20 B | $69.72 B |
| US-listed rank | #2522 | #249 |
| Revenue (latest FY) | $83.81M | $20.07B |
| Net income (latest FY) | $22.48M | - |
| Net margin | 26.8% | - |
| P/E (trailing FY) | 53.2 | - |
| SEC filings | 760 | 1,009 |
BOSTON SCIENTIFIC CORP is 58.3x more valuable than IRADIMED CORP by market capitalization ($69.72 B vs $1.20 B).
In their latest fiscal years, IRADIMED CORP reported $83.81M in revenue while BOSTON SCIENTIFIC CORP reported $20.07B.
Full pages: IRADIMED CORP and BOSTON SCIENTIFIC CORP, or browse the full rankings.